RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 76 filers reported holding RA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $4,047,000 | +17.0% | 134,600 | -12.8% | 0.28% | +75.6% |
| Q1 2019 | $3,458,000 | +929.2% | 154,400 | +289.9% | 0.16% | +788.9% |
| Q4 2017 | $336,000 | -28.1% | 39,600 | +23.8% | 0.02% | -28.0% |
| Q3 2017 | $467,000 | -56.6% | 32,000 | -44.3% | 0.02% | -62.1% |
| Q2 2017 | $1,075,000 | +53.6% | 57,400 | +74.5% | 0.07% | +50.0% |
| Q1 2017 | $700,000 | – | 32,900 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|